92
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Calculated Fast-growing Benign Prostatic Hyperplasia

&
Pages 330-338 | Published online: 09 Jul 2009

  • Denis L, Griffiths K, Khoury S, Cockett ATK, McConnell, Chatelain C, et al. In: 4th International Consultation on Benign Prostatic Hyperplasia (BPH), Proceedings 4. Plymebridge Distributors Ltd, Plymouth, United Kingdom, 1998.
  • Kirby R, Christmas T, Brawer M. Chapter 3. In: Prostate Cancer, Mosby, an imprint of Times Mirror International Publishers Limited, 1996.
  • McNeal J. Pathology of benign prostatic hyperplasia. Urol. Clin. N. Am. 1990; 17: 477-86.
  • Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, et al. Latent carcinoma of the prostate at autopsy in seven areas. Int. J. Cancer 1977; 20: 680-8.
  • Armenian HK, Lilenfeld AM, Diamond EL, Bross IDJ. Relation between benign prostatic hyperplasia and cancer of the prostate. Lancet 1974; 2: 115-17.
  • Tiblin G. Prostatic cancer: the men born in 1913 study. In: Medical Products Agency: workshop: pharmacological treatment of prostatic cancer, Vol. 3. Uppsala, Sweden: Medical Products Agency. 1993: 13-9.
  • Greenwald P, Kirmss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J. Natl. Cancer Inst. 1974; 53: 335-40.
  • Hammarsten J, Andersson S, Holmén A, Högstedt B, Peeker R. Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study. Cancer 1994; 74: 2347-51.
  • Lund K, Ewertz M, Schou G. Breast cancer incidence subsequent to surgical reduction of the female breast. Scand. J. Plast. Reconstr. Surg. 1987; 21: 209-12.
  • Mostofi FK, Sesterhenn I, Sobin LH. Histological typing of prostate tumours, International histological classification of tumors No.> 22, WHO, Geneva, 1980.
  • Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl. 1992; 4: 129-38.
  • Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening--Part II. Accuracy of in vitro and in vivo techniques. Radiology 1991; 179: 49-53.
  • Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J. Urol. 1991; 145: 984-7.
  • Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J. Urol. 1984; 132: 474-9.
  • Gay JM. Clinical epidemiology and evidence-based medicine glossary. In: Terminology Specific to Epidemiology, updated August 22, 1999, page 2 http:// www.vetmed.wsu.edu./courses-jmgay/GlossEpiTerminology.htm
  • Hammarsten J, Högstedt B, Holthuis N, Mellström D. Components of the metabolic syndrome--risk factors for the development of benign prostatic hyperplasia. Prostate cancer and prostatic diseases 1998; 1: 157-62.
  • Hammarsten J, Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood pressure 1999; 8: 29-36.
  • Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. European Urology 2001; 39: 151-8.
  • Reavan GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
  • Rett K, Wicklmayr M, Mehnert H. New aspects of insulin resistance in hypertension. European Heart Journal 1994; 15 (Supplement C): 78-81.
  • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991 ;14: 173-94.
  • Krotkiewski M. Role of muscle capillarization and morphology in the development of insulin resistance and metabolic syndrome. Presse Med. 1994; 23: 1353-6.
  • Timar O, Sestier F, Levy E. Metabolic syndrome X: a review. Can. J. Cardiol. 2000; 16: 779-89.
  • Lithell H. In: Insulinresistens. En bas för förståelsen av kardiovaskuläre sjukdomars etiologi och behandling. Bristol-Myers Squibb AB 1992.
  • Gleason DF. Histologie grading of prostate cancer: a perspective. Human Pathology 1992; 23: 273-9.
  • Morton MS, Blacklock N, Denis E, Griffiths K. Western diet and prostate cancer: does the available evidence justify dietary advice. In: Schröder FH. Recent advances in prostate cancer and BPH. New York: The Parthenon Publishing Group Inc., 1996: 61-74.
  • Kalkhoff RK, Kim HJ, Cerletty J, Ferrou CA. Metabolic effects of weight loss in obese subjects. Changes in plasma substrate levels, insulin and growth hormone responses. Diabetes 1971; 20: 83-91.
  • Nilsson PM, Eindholm EH, Scherstén BF. Life style changes improve insulin resistance in hyperinsulinaemic subjects: a one-year intervention study of hypertensives and normotensives in Dalby. J. Hypertens. 1992; 10: 1071-78.
  • Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. Effects of weight loss in massive obesity on insulin and c-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. Endocrinol Metab. 1987; 64: 661-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.